Holen Sie sich die Stockscreener-App
1.22
3.94%
-0.05
Handel nachbörslich:
1.22
Finanzdaten der Jasper Therapeutics Inc-Aktie (JSPR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Cost Of Revenue |
9.345
|
- | - | - | - |
Operating Expenses
|
12.09%
19.17
|
21.80 | 25.29 | 19.89 | 15.99 |
| Operating Income/Loss |
12.09%
-19.17
|
-21.80 | -25.29 | -19.89 | -15.99 |
| Nonoperating Income/Loss |
23.35%
0.43
|
0.561 | 0.964 | 1.252 | 1.41 |
| Income/Loss From Continuing Operations Before Tax |
11.79%
-18.74
|
-21.24 | -24.32 | -18.64 | -14.58 |
| Income/Loss From Continuing Operations After Tax |
11.79%
-18.74
|
-21.24 | -24.32 | -18.64 | -14.58 |
|
Net Income/Loss
|
11.79%
-18.74
|
-21.24 | -24.32 | -18.64 | -14.58 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.74%
16.64
|
15.02 | 0.1422 | 15.00 | 14.99 |
| Diluted Average Shares |
10.74%
16.64
|
15.02 | 0.1422 | 15.00 | 14.99 |
| Basic Earnings Per Share |
19.86%
-1.13
|
-1.41 | -1.64 | -1.24 | -0.97 |
| Diluted Earnings Per Share |
19.86%
-1.13
|
-1.41 | -1.64 | -1.24 | -0.97 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):